Sahsen Ventures
Sahsen is a venture capital firm that makes investments in life science and education sectors.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Sahsen Ventures Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Sahsen is a venture capital firm that makes investments in life science and education sectors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2016 | Owl Rock Capital | Venture Round | - |
| 7/2020 | Elegen | Seed Round | - |
| 1/2006 | R BABY FOUNDATION | Venture Round | - |
| 1/2021 | Inspire | Venture Round | - |
| 1/2020 | Agerpoint | Series C | - |
| 1/2017 | Thorn | Venture Round | - |
| 1/2000 | The Dian Fossey Gorilla Fund | Venture Round | - |
| 1/2013 | Landesa | Venture Round | - |
| 1/2013 | Washington Environmental Council | Venture Round | - |
| 9/2017 | TwinStrand Biosciences | Venture Round | 5.3M |
| 1/2010 | Plymouth Housing | Venture Round | - |
| 1/2016 | GARDEN ISLAND RESOURCE CONSERVATION AND DEVELOPMENT | Venture Round | - |
| 1/2017 | Icosavax | Pre Seed Round | - |
| 1/2000 | Galapagos Conservancy | Venture Round | - |
| 1/2000 | Pacific Wildlife Project | Venture Round | - |
| 5/2019 | Phathom Pharmaceuticals | Private Equity Round | 90M |
| 7/2016 | 98point6 | Series A | 12.6M |
| 1/2019 | Azitra | Venture Round | - |
| 1/2014 | Adaptimmune | Venture Round | - |
| 5/2020 | Kriya Therapeutics | Series A | 0 |
| 10/2018 | Lyell Immunopharma | Series A | - |
| 9/2019 | A-Alpha Bio | Seed Round | 0 |
| 1/2018 | Forterra | Venture Round | - |
| 1/2016 | Earth Economics | Venture Round | - |
| 1/2015 | AgeneBio | Venture Round | - |
| 6/2018 | Checkerspot | Seed Round | 5M |
| 5/2014 | Roivant Sciences | Private Equity Round | 0 |
| 10/2018 | Parse Biosciences | Seed Round | 1.2M |
| 1/2010 | Amara | Venture Round | - |
| 2/2017 | Rocket Pharmaceuticals | Post-IPO Equity | - |
| 1/2005 | Ashesi University | Venture Round | - |
| 1/2020 | TwinStrand Biosciences | Series A | 16M |
| 10/2011 | Puma Biotechnology | Post-IPO Equity | 55M |
| 1/2019 | Phase Genomics | Venture Round | - |
| 1/2004 | Math for America | Seed Round | - |
| 1/2017 | Water1st International | Venture Round | - |
| 1/2002 | The CCR | Venture Round | - |
| 1/2017 | PolarisProject | Venture Round | - |
| 1/2018 | PvP Biologics | Venture Round | - |
| 1/2000 | PESTICIDE ACTION NETWORK NORTH AMERICA | Venture Round | - |
| 1/2020 | NuProbe | Venture Round | - |
| 8/2022 | Monod Bio | Seed Round | 0 |
| 1/2016 | Fred Hutchinson | Venture Round | - |
| 1/2017 | MP Materials | Venture Round | - |
| 4/2019 | Checkerspot | Series A | 13M |
| 1/2013 | Institute for Protein Design | Venture Round | - |
| 1/2009 | INSTITUTE FOR STEM CELL AND REGENERATIVE MEDICINE | Venture Round | - |
| 1/2008 | Centre for Infectious Disease Research | Venture Round | - |
| 1/2019 | Impact Vitals | Venture Round | - |
| 9/2014 | TRACON Pharmaceuticals | Series B | 0 |
| 1/2002 | Canada Green Building Council | Venture Round | - |
| 3/2021 | Outpace Bio | Series A | 30M |
| 2/2016 | Magic Leap | Series C | 793.5M |
| 1/2016 | BROTMAN BATY INSTITUTE | Venture Round | - |
| 10/2019 | Variant Bio | Series A | 24.7M |
| 1/2016 | Uterish | Seed Round | - |
| 1/2017 | Potlatch Fund | Venture Round | - |
| 10/2012 | Genocea Biosciences | Series C | 30M |
| 5/2021 | Dyno Therapeutics | Series A | 100M |
| 5/2018 | Avail Medsystems | Series A | 12.9M |
| 1/2013 | Context Logic | Venture Round | - |
| 1/2020 | Andes | Venture Round | - |
| 1/2018 | Neoleukin Therapeutics | Venture Round | - |
| 1/2017 | Amplio | Venture Round | - |
| 1/2000 | Brady | Venture Round | - |
| 10/2016 | Recursion Pharmaceuticals | Series A | 12.9M |
| 8/2017 | SiDx | Venture Round | 1.5M |
| 6/2018 | Ant Group | Series C | 14B |
| 1/2000 | NARAL Pro-Choice America | Venture Round | - |
| 6/2017 | Illumio | Series D | 125M |
| 6/2020 | Athira Pharma | Series B | 85M |
| 1/2019 | Sana Biotechnology | Seed Round | - |
| 3/2023 | Outpace Bio | Series A | 0 |
| 9/2021 | HilleVax | Equity | 135M |
| 2/2022 | Terray Therapeutics | Series A | 0 |
| 1/2000 | NORTHWEST HARVEST | Venture Round | - |
| 1/2011 | Ocean Futures Society | Venture Round | - |
| 1/2000 | Pomona College | Venture Round | - |
| 1/2000 | Queens College | Venture Round | - |
| 2/2022 | Terray Therapeutics | Series A | 0 |
| 9/2021 | HilleVax | Venture Round | 0 |
| 5/2021 | Dyno Therapeutics | Series A | 0 |
| 3/2021 | Outpace Bio | Series A | 0 |
| 1/2021 | Inspire | Venture Round | - |
| 7/2020 | Elegen | Seed Round | - |
| 6/2020 | Athira Pharma | Series B | 0 |
| 5/2020 | Kriya Therapeutics | Series A | 0 |
| 1/2020 | TwinStrand Biosciences | Series A | 0 |
| 1/2020 | Andes | Venture Round | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
